List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 210 studies with search of: "Lupus"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Conditions: Immunologic Diseases;   Autoimmune Diseases;   Systemic Lupus Erythematosus;   Lupus Nephritis;   Lupus Glomerulonephritis
Intervention: Drug: Abetimus sodium (LJP 394)
2 Recruiting Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
3 Recruiting Study of Systemic Lupus Erythematosus
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention:
4 Recruiting Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
5 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: cyclophosphamide
6 Terminated Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
7 Recruiting TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: infliximab;   Drug: placebo
8 Completed Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
Conditions: Glomerulonephritis;   Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: SQ Fludarabine
9 Completed Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Intervention: Drug: tacrolimus
10 Recruiting A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Interventions: Drug: corticosteroids;   Drug: cyclophosphamide;   Drug: mycophenolate mofetil;   Drug: ocrelizumab;   Drug: placebo
11 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
12 Recruiting European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Intervention: Procedure: laboratory analysis
13 Recruiting New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Conditions: Systemic Lupus Erythematosus;   Lupus
Intervention: Drug: Triptorelin
14 Recruiting The Research Registry for Neonatal Lupus
Conditions: Neonatal Lupus;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Congenital Heart Block
Intervention:
15 Completed Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Conditions: Systemic Lupus Erythematosus;   Lupus
Interventions: Drug: pravastatin;   Drug: aspirin;   Drug: ramipril;   Drug: Vitamins: B6, B12, and folate;   Behavioral: heart health educational program
16 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
17 Recruiting Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition: Discoid Lupus Erythematosus
Intervention: Drug: CC-10004
18 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
19 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream applied twice daily;   Drug: Cream vehicle for ASF 1096 cream applied twice daily
20 Not yet recruiting Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-Like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services